| 1 |
Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis [J]. Lancet Neurol, 2011, 10(1): 63-74.
|
| 2 |
Titulaer MJ, Mccracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study [J]. Lancet Neurol, 2013, 12(2): 157-165.
|
| 3 |
Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia [J]. Brain, 2010, 133(9): 2734-2748.
|
| 4 |
Finke C, Kopp UA, Pruss H, et al. Cognitive deficits following anti-NMDA receptor encephalitis [J]. J Neurol Neurosurg Psychiatry, 2012, 83(2): 195-198.
|
| 5 |
Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes [J]. Brain, 2010, 133(6): 1655-1667.
|
| 6 |
Wegner F, Wilke F, Raab P, et al. Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography [J]. BMC Neurol, 2014, 14: 136-147.
|
| 7 |
Tobin WO, Strand EA, Clark HM, et al. NMDA receptor encephalitis causing reversible caudate changes on MRI and PET imaging [J]. Neurol Clin Pract, 2014, 4(6): 470-473.
|
| 8 |
Yuan J, Guan H, Zhou X, et al. Changing brain metabolism patterns in patients with ANMDARE: serial 18F-FDG PET/CT findings [J]. Clin Nucl Med, 2016, 41(5): 366-370.
|
| 9 |
Kimura N, Kumamoto T, Takahashi Y. Brain perfusion SPECT in limbic encephalitis associated with autoantibody against the glutamate receptor epsilon 2 [J]. Clin Neurol Neurosurg, 2014, 118: 44-48.
|
| 10 |
Taguchi Y, Takashima S, Nukui T, et al. Reversible "brain atrophy" in anti-NMDA receptor encephalitis [J]. Intern Med, 2011, 50(21): 2697.
|
| 11 |
Iizuka T, Kaneko J, Tominaga N, et al. Association of progressive cerebellar atrophy with long-term outcome in patients with anti-N-methyl-D-aspartate receptor encephalitis [J]. JAMA Neurol, 2016, 73(6): 706-713.
|
| 12 |
Benarroch EE. Potassium channels: brief overview and implications in epilepsy [J]. Neurology, 2009, 72(7): 664-669.
|
| 13 |
Klein CJ, Lennon VA, Aston PA, et al. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping [J]. JAMA Neurol, 2013, 70(2): 229-234.
|
| 14 |
Irani SR, Stagg CJ, Schott JM, et al. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype [J]. Brain, 2013, 136(10): 3151-3162.
|
| 15 |
Joubert B, Saint-Martin M, Noraz N, et al. Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures [J]. JAMA Neurol, 2016, 73(9): 1115-1124.
|
| 16 |
Sunwoo JS, Lee ST, Byun JI, et al. Clinical manifestations of patients with CASPR2 antibodies [J]. J Neuroimmunol, 2015, 281: 17-22.
|
| 17 |
Bien CG, Mirzadjanova Z, Baumgartner C, et al. Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome [J]. Eur J Neurol, 2017, 24(1): 175-186.
|
| 18 |
Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins [J]. Neurology, 2011, 77(2): 179-189.
|
| 19 |
Spinazzi M, Argentiero V, Zuliani L, et al. Immunotherapy-reversed compulsive, monoaminergic, circadian rhythm disorder in Morvan syndrome [J]. Neurology, 2008, 71(24): 2008-2010.
|
| 20 |
Toosy AT, Burbridge SE, Pitkanen M, et al. Functional imaging correlates of fronto-temporal dysfunction in Morvan's syndrome [J]. J Neurol Neurosurg Psychiatry, 2008, 79(6): 734-735.
|
| 21 |
Lancaster E, Huijbers MG, Bar V, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia [J]. Ann Neurol, 2011, 69(2): 303-311.
|
| 22 |
Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen [J]. Lancet Neurol, 2010, 9(1): 67-76.
|
| 23 |
徐秦岚, 崔韬, 史伟雄, 等. 以癫痫发作起病的抗GABAB受体脑炎六例 [J]. 脑与神经疾病杂志, 2018, 26(7): 405-410.
|
| 24 |
Hoftberger R, Titulaer MJ, Sabater L, et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients [J]. Neurology, 2013, 81(17): 1500-1506.
|
| 25 |
Su M, Xu D, Tian R. (18)F-FDG PET/CT and MRI findings in a patient with anti-GABA(B) receptor encephalitis [J]. Clin Nucl Med, 2015, 40(6): 515-517.
|
| 26 |
Ohta K, Seki M, Dalmau J, et al. Perfusion IMP-SPECT shows reversible abnormalities in GABA(B) receptor antibody associated encephalitis with normal MRI [J]. Brain Behav, 2011, 1(2): 70-72.
|
| 27 |
Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location [J]. Ann Neurol, 2009, 65(4): 424-434.
|
| 28 |
Hoftberger R, Van Sonderen A, Leypoldt F, et al. Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients [J]. Neurology, 2015, 84(24): 2403-2412.
|
| 29 |
Wei YC, Liu CH, Lin JJ, et al. Rapid progression and brain atrophy in anti-AMPA receptor encephalitis [J]. J Neuroimmunol, 2013, 261(1-2): 129-133.
|
| 30 |
Spatola M, Stojanova V, Prior JO, et al. Serial brain (1)(8)FDG-PET in anti-AMPA receptor limbic encephalitis [J]. J Neuroimmunol, 2014, 271(1-2): 53-55.
|
| 31 |
Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients [J]. Brain, 2000, 123(7): 1481-1494.
|
| 32 |
Helga C, Carlo M, Francesca M, et al. The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer [J]. Medicine, 2019, 98: 35-43.
|
| 33 |
Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis [J]. Brain, 2012, 135(Pt 5): 1622-1638.
|
| 34 |
Ronnyson SG, Wagner CC, Luiz HC, et al. Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes [J]. Curr Oncol Rep, 2018, 20: 92-103.
|
| 35 |
Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2- associated encephalitis [J]. Brain, 2004, 127(Pt 8): 1831-1844.
|
| 36 |
Da Rocha AJ, Nunes RH, Maia ACJr, et al. Recognizing autoimmune-mediated encephalitis in the differential diagnosis of limbic disorders [J]. AJNR Am J Neuroradiol, 2015, 36(12): 2196-2205.
|
| 37 |
朱莎, 赵春维, 肖丹青, 等. 自身免疫性脑炎相关性癫痫发作的研究进展 [J]. 癫痫杂志, 2015, 1(1): 70-72.
|
| 38 |
Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS [J]. J Neurol, 2010, 257(4): 509-517.
|